- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Capecitabine, 1000 mg/m2
Total 763 results
-
Hadassah Medical OrganizationUnknownBreast NeoplasmsIsrael
-
Institut für Klinische Krebsforschung IKF GmbH...Bristol-Myers SquibbActive, not recruitingPleural Mesothelioma MalignantGermany
-
Meirav Kedmi MDJohnson & JohnsonUnknownDiffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent LymphomaIsrael
-
PurGenesis Technologies Inc.CompletedLeft-Sided Ulcerative Colitis | ProctosigmoiditisGermany
-
Aileron Therapeutics, Inc.TerminatedPrevention of Chemotherapy-induced MyelosuppressionUnited States, Bosnia and Herzegovina, Serbia, Bulgaria
-
Xinhua Hospital, Shanghai Jiao Tong University...Completed
-
Xiayun He, MDCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Hutchison Medipharma LimitedTerminatedUlcerative ColitisUnited States
-
Royan InstituteCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Janssen Sciences Ireland UCCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
Nektar TherapeuticsCompletedColorectal Cancer | TumorUnited States
-
Medicines for Malaria VentureWashington University School of Medicine; Sanaria Inc.; Institute of Tropical... and other collaboratorsCompleted
-
GlaxoSmithKlineWithdrawn
-
Institute of Hematology & Blood Diseases Hospital...RecruitingAcute Myeloid LeukemiaChina
-
Emergent BioSolutionsQuintiles, Inc.; Unither VirologyCompleted
-
CymaBay Therapeutics, Inc.Completed
-
Bial - Portela C S.A.Terminated
-
Hao LongRecruitingChemotherapy | Safety | Biomarker | TislelizumabChina
-
Sun Yat-sen UniversityTerminatedCarcinoma Breast Stage IVChina
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos IIIRecruiting
-
Mohamed Gaber AllamKing Abdul Aziz Specialist HospitalCompletedPatients With Respiratory Failure and ShockedSaudi Arabia
-
GlaxoSmithKlineCompletedToothacheUnited Kingdom, Italy, Korea, Republic of
-
University of BrawijayaSaiful Anwar HospitalRecruitingPacemaker ComplicationIndonesia
-
Acticor BiotechActive, not recruitingAcute Ischemic StrokeUnited States, Germany
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
Tianjin Hemay Pharmaceutical Co., LtdCompleted
-
GlaxoSmithKlineCompletedAutoimmune DiseasesUnited Kingdom
-
Idorsia Pharmaceuticals Ltd.Terminated
-
University of PadovaTerminatedCirrhosis | Ascites | Nosocomial Spontaneous Bacterial PeritonitisItaly
-
Stendhal Americas, S.A.LG Chem; Universidad Nacional Autonoma de MexicoCompletedDiabetes Mellitus, Type 2Mexico
-
MedImmune LLCCompletedSystemic Lupus ErythematosusUnited States, Brazil, Bulgaria, Czech Republic, Korea, Republic of, Mexico, Peru, Hungary, Poland, Romania, Ukraine, Taiwan, India, Colombia
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Rutgers, The State University of New JerseyRecruitingPancreatic CancerUnited States
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
Dr. Reddy's Laboratories LimitedCompleted
-
Baylor College of MedicinePharmacosmos Therapeutics, Inc.RecruitingAnemia, Iron Deficiency | Uterine BleedingUnited States
-
Vifor PharmaCompletedChronic Kidney DiseaseUnited States, Switzerland, Romania, Croatia, Bulgaria, Germany, Czech Republic, Poland, Russian Federation
-
University of PittsburghNational Cancer Institute (NCI)Completed
-
Ranbaxy Laboratories LimitedCompletedHealthyUnited States
-
Ranbaxy Laboratories LimitedCompletedHealthyUnited States
-
University of California, DavisMars, Inc.CompletedHealthyUnited States
-
ShionogiCompleted
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada
-
ShionogiCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Theratocular Biotek Co.Recruiting
-
Marc Y.DonathCompletedType 2 DiabetesSwitzerland